Allergan plc (AGN) New York Stock Exchange
138.78-1.42-1.01%
CloseMay 20, 2019

News: updated – 20-May 10:08


Allergan And Cenicriviroc In NASH: The Forgotten19-May 07:03(SeekingAlpha)

Market Assessment Allergan ( AGN ) is a commercial-stage large market cap ($45.9B) biopharma developing innovative and generic therapeutics for diseases affecting the eyes, bowel, lungs, skin, urogenital systems and brain. Through the acquisition of Tobira Therapeutics, Allergan has been…